436 related articles for article (PubMed ID: 12630566)
1. The role of caspase cascade on the development of primary Sjögren's syndrome.
Hayashi Y; Arakaki R; Ishimaru N
J Med Invest; 2003 Feb; 50(1-2):32-8. PubMed ID: 12630566
[TBL] [Abstract][Full Text] [Related]
2. Involvement of apoptotic protease cascade for tissue destruction in Sjögren's syndrome.
Hayashi Y; Yayagi K; Haneji N
Arch Immunol Ther Exp (Warsz); 2000; 48(5):399-403. PubMed ID: 11140467
[TBL] [Abstract][Full Text] [Related]
3. Prevention and induction of autoimmune exocrinopathy is dependent on pathogenic autoantigen cleavage in murine Sjögren's syndrome.
Saegusa K; Ishimaru N; Yanagi K; Mishima K; Arakaki R; Suda T; Saito I; Hayashi Y
J Immunol; 2002 Jul; 169(2):1050-7. PubMed ID: 12097413
[TBL] [Abstract][Full Text] [Related]
4. Detection of cleaved alpha-fodrin autoantigen in Sjögren's syndrome: apoptosis and co-localisation of cleaved alpha-fodrin with activated caspase-3 and cleaved poly(ADP-ribose) polymerase (PARP) in labial salivary glands.
Wang Y; Virji AS; Howard P; Sayani Y; Zhang J; Achu P; McArthur C
Arch Oral Biol; 2006 Jul; 51(7):558-66. PubMed ID: 16405863
[TBL] [Abstract][Full Text] [Related]
5. Development of autoimmune exocrinopathy resembling Sjögren's syndrome in adoptively transferred mice with autoreactive CD4+ T cells.
Arakaki R; Ishimaru N; Saito I; Kobayashi M; Yasui N; Sumida T; Hayashi Y
Arthritis Rheum; 2003 Dec; 48(12):3603-9. PubMed ID: 14674013
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis and Sjögren syndrome.
Manganelli P; Fietta P
Semin Arthritis Rheum; 2003 Aug; 33(1):49-65. PubMed ID: 12920696
[TBL] [Abstract][Full Text] [Related]
7. Severe destructive autoimmune lesions with aging in murine Sjögren's syndrome through Fas-mediated apoptosis.
Ishimaru N; Yoneda T; Saegusa K; Yanagi K; Haneji N; Moriyama K; Saito I; Hayashi Y
Am J Pathol; 2000 May; 156(5):1557-64. PubMed ID: 10793067
[TBL] [Abstract][Full Text] [Related]
8. Development of autoimmune arthritis with aging via bystander T cell activation in the mouse model of Sjögren's syndrome.
Kobayashi M; Yasui N; Ishimaru N; Arakaki R; Hayashi Y
Arthritis Rheum; 2004 Dec; 50(12):3974-84. PubMed ID: 15593201
[TBL] [Abstract][Full Text] [Related]
9. Treatment of chronic sialadenitis in a murine model of Sjögren's syndrome by local fasL gene transfer.
Fleck M; Zhang HG; Kern ER; Hsu HC; Müller-Ladner U; Mountz JD
Arthritis Rheum; 2001 Apr; 44(4):964-73. PubMed ID: 11315936
[TBL] [Abstract][Full Text] [Related]
10. Possible involvement of EBV-mediated alpha-fodrin cleavage for organ-specific autoantigen in Sjogren's syndrome.
Inoue H; Tsubota K; Ono M; Kizu Y; Mizuno F; Takada K; Yamada K; Yanagi K; Hayashi Y; Saito I
J Immunol; 2001 May; 166(9):5801-9. PubMed ID: 11313424
[TBL] [Abstract][Full Text] [Related]
11. The role of Fas-Fas ligand-mediated apoptosis in autoimmune lacrimal gland disease in MRL/MpJ mice.
Jabs DA; Lee B; Whittum-Hudson J; Prendergast RA
Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):399-401. PubMed ID: 11157873
[TBL] [Abstract][Full Text] [Related]
12. Elevated proapoptotic Bax and caspase 3 activation in the NOD.scid model of Sjögren's syndrome.
Masago R; Aiba-Masago S; Talal N; Zuluaga FJ; Al-Hashimi I; Moody M; Lau CA; Peck AB; Brayer J; Humphreys-Beher MG; Dang H
Arthritis Rheum; 2001 Mar; 44(3):693-702. PubMed ID: 11263785
[TBL] [Abstract][Full Text] [Related]
13. Fas ligand-mediated exocrinopathy resembling Sjögren's syndrome in mice transgenic for IL-10.
Saito I; Haruta K; Shimuta M; Inoue H; Sakurai H; Yamada K; Ishimaru N; Higashiyama H; Sumida T; Ishida H; Suda T; Noda T; Hayashi Y; Tsubota K
J Immunol; 1999 Mar; 162(5):2488-94. PubMed ID: 10072487
[TBL] [Abstract][Full Text] [Related]
14. Transfer of Sjögren's syndrome-like autoimmune lesions into SCID mice and prevention of lesions by anti-CD4 and anti-T cell receptor antibody treatment.
Hayashi Y; Haneji N; Hamano H; Yanagi K
Eur J Immunol; 1994 Nov; 24(11):2826-31. PubMed ID: 7957574
[TBL] [Abstract][Full Text] [Related]
15. Induction of salivary gland epithelial cell injury in Sjogren's syndrome: in vitro assessment of T cell-derived cytokines and Fas protein expression.
Abu-Helu RF; Dimitriou ID; Kapsogeorgou EK; Moutsopoulos HM; Manoussakis MN
J Autoimmun; 2001 Sep; 17(2):141-53. PubMed ID: 11591123
[TBL] [Abstract][Full Text] [Related]
16. Analysis of in vivo role of alpha-fodrin autoantigen in primary Sjogren's syndrome.
Miyazaki K; Takeda N; Ishimaru N; Omotehara F; Arakaki R; Hayashi Y
Am J Pathol; 2005 Oct; 167(4):1051-9. PubMed ID: 16192640
[TBL] [Abstract][Full Text] [Related]
17. Effective treatment of a mouse model of Sjögren's syndrome with eyedrop administration of anti-CD4 monoclonal antibody.
Hayashi Y; Ishimaru N; Arakaki R; Tsukumo S; Fukui H; Kishihara K; Shiota H; Yasutomo K; Hayashi Y
Arthritis Rheum; 2004 Sep; 50(9):2903-10. PubMed ID: 15457459
[TBL] [Abstract][Full Text] [Related]
18. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
Humphreys-Beher MG; Yamachika S; Yamamoto H; Maeda N; Nakagawa Y; Peck AB; Robinson CP
Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931
[TBL] [Abstract][Full Text] [Related]
19. Sjögren's syndrome. Controversies and progress.
Fox RI
Clin Lab Med; 1997 Sep; 17(3):431-44. PubMed ID: 9316767
[TBL] [Abstract][Full Text] [Related]
20. Non-depleting anti-CD4 antibody not only prevents onset but resolves sialadenitis in NOD mice.
Thompson C; Jacobsen H; Pomeranz Krummel D; Nagai K; Cooke A
Autoimmunity; 2004 Dec; 37(8):549-54. PubMed ID: 15763917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]